BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 35269461)

  • 1. What's in a Gene? The Outstanding Diversity of
    Ruiz-Gabarre D; Carnero-Espejo A; Ávila J; García-Escudero V
    Cells; 2022 Mar; 11(5):. PubMed ID: 35269461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tau Isoforms: Gaining Insight into
    Corsi A; Bombieri C; Valenti MT; Romanelli MG
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intron retention as a productive mechanism in human MAPT: RNA species generated by retention of intron 3.
    Ruiz-Gabarre D; Vallés-Saiz L; Carnero-Espejo A; Ferrer I; Hernández F; Garcia-Escudero R; Ávila J; García-Escudero V
    EBioMedicine; 2024 Feb; 100():104953. PubMed ID: 38181704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tau alternative splicing in familial and sporadic tauopathies.
    Niblock M; Gallo JM
    Biochem Soc Trans; 2012 Aug; 40(4):677-80. PubMed ID: 22817715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysregulated coordination of MAPT exon 2 and exon 10 splicing underlies different tau pathologies in PSP and AD.
    Bowles KR; Pugh DA; Oja LM; Jadow BM; Farrell K; Whitney K; Sharma A; Cherry JD; Raj T; Pereira AC; Crary JF; Goate AM
    Acta Neuropathol; 2022 Feb; 143(2):225-243. PubMed ID: 34874463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Tau Proteoforms in Health and Disease.
    Waheed Z; Choudhary J; Jatala FH; Fatimah ; Noor A; Zerr I; Zafar S
    Mol Neurobiol; 2023 Sep; 60(9):5155-5166. PubMed ID: 37266762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tau Interacting Proteins: Gaining Insight into the Roles of Tau in Health and Disease.
    Stancu IC; Ferraiolo M; Terwel D; Dewachter I
    Adv Exp Med Biol; 2019; 1184():145-166. PubMed ID: 32096036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MAPT expression and splicing is differentially regulated by brain region: relation to genotype and implication for tauopathies.
    Trabzuni D; Wray S; Vandrovcova J; Ramasamy A; Walker R; Smith C; Luk C; Gibbs JR; Dillman A; Hernandez DG; Arepalli S; Singleton AB; Cookson MR; Pittman AM; de Silva R; Weale ME; Hardy J; Ryten M
    Hum Mol Genet; 2012 Sep; 21(18):4094-103. PubMed ID: 22723018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early maturation and distinct tau pathology in induced pluripotent stem cell-derived neurons from patients with MAPT mutations.
    Iovino M; Agathou S; González-Rueda A; Del Castillo Velasco-Herrera M; Borroni B; Alberici A; Lynch T; O'Dowd S; Geti I; Gaffney D; Vallier L; Paulsen O; Káradóttir RT; Spillantini MG
    Brain; 2015 Nov; 138(Pt 11):3345-59. PubMed ID: 26220942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haplotype-specific MAPT exon 3 expression regulated by common intronic polymorphisms associated with Parkinsonian disorders.
    Lai MC; Bechy AL; Denk F; Collins E; Gavriliouk M; Zaugg JB; Ryan BJ; Wade-Martins R; Caffrey TM
    Mol Neurodegener; 2017 Oct; 12(1):79. PubMed ID: 29084565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative splicing of exon 10 in the tau gene as a target for treatment of tauopathies.
    Zhou J; Yu Q; Zou T
    BMC Neurosci; 2008 Dec; 9 Suppl 2(Suppl 2):S10. PubMed ID: 19090983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative promoter usage generates novel shorter MAPT mRNA transcripts in Alzheimer's disease and progressive supranuclear palsy brains.
    Huin V; Buée L; Behal H; Labreuche J; Sablonnière B; Dhaenens CM
    Sci Rep; 2017 Oct; 7(1):12589. PubMed ID: 28974731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of Tau Isoforms Imbalance Precludes Tau Pathology and Cognitive Decline in a Mouse Model of Tauopathy.
    Espíndola SL; Damianich A; Alvarez RJ; Sartor M; Belforte JE; Ferrario JE; Gallo JM; Avale ME
    Cell Rep; 2018 Apr; 23(3):709-715. PubMed ID: 29669277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The six brain-specific TAU isoforms and their role in Alzheimer's disease and related neurodegenerative dementia syndromes.
    Buchholz S; Zempel H
    Alzheimers Dement; 2024 May; 20(5):3606-3628. PubMed ID: 38556838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia alters expression of zebrafish microtubule-associated protein tau (mapta, maptb) gene transcripts.
    Moussavi Nik SH; Newman M; Ganesan S; Chen M; Martins R; Verdile G; Lardelli M
    BMC Res Notes; 2014 Oct; 7():767. PubMed ID: 25359609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative analysis of tau isoform transcripts in sporadic tauopathies.
    Connell JW; Rodriguez-Martin T; Gibb GM; Kahn NM; Grierson AJ; Hanger DP; Revesz T; Lantos PL; Anderton BH; Gallo JM
    Brain Res Mol Brain Res; 2005 Jun; 137(1-2):104-9. PubMed ID: 15950767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An SRp75/hnRNPG complex interacting with hnRNPE2 regulates the 5' splice site of tau exon 10, whose misregulation causes frontotemporal dementia.
    Wang Y; Wang J; Gao L; Stamm S; Andreadis A
    Gene; 2011 Oct; 485(2):130-8. PubMed ID: 21723381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complex splicing and neural expression of duplicated tau genes in zebrafish embryos.
    Chen M; Martins RN; Lardelli M
    J Alzheimers Dis; 2009; 18(2):305-17. PubMed ID: 19584432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dementia Therapy Targeting Tau.
    Buee L
    Adv Exp Med Biol; 2019; 1184():407-416. PubMed ID: 32096053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The genetics of dementias. Part 1: Molecular basis of frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)].
    Kowalska A
    Postepy Hig Med Dosw (Online); 2009 Jun; 63():278-86. PubMed ID: 19535823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.